Contact
GT-11

GT-11 A85494 (Previously 857395) N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanamide

GT-11

GT-11 Dihydroceramide Desaturase Inhibitor

GT-11, also N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanamide, is the first inhibitor of dihydroceramide desaturase, an enzyme that converts dihydroceramide into the bioactive compound ceramide.

Dihydroceramides desaturase is an enzyme involved in the biosynthesis of ceramides. Ceramides are important molecules in the structure of cell membranes that contribute to various cellular processes including cell signaling and apoptosis, also referred to as programmed cell death. By inhibiting the activity of dihydroceramides desaturase, GT-11 can affect the production of ceramides, altering various cellular processes and pathways in which ceramides are involved.

00000000
$0.00
Buy
Please confirm your location

Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate location button below.

For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!

*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada